| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.6M | -19.0% |
| SG&A Expense | $5.2M | -17.8% |
| Pre-tax Income | -$12.8M | -111.5% |
| Income Tax | $0 | — |
| Net Income | -$12.8M | -111.5% |
| EPS (Basic) | $10.99 | +1031.4% |
| EPS (Diluted) | $10.99 | +1031.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.7M | -38.4% |
| Current Assets | $17.7M | -42.0% |
| Total Assets | $17.7M | -43.0% |
| Current Liabilities | $1.0M | -76.3% |
| Total Liabilities | $11.0M | +98.2% |
| Stockholders' Equity | $5.9M | -75.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.9M | +5.6% |
| Capital Expenditures | $3K | +0.0% |
| Investing Cash Flow | -$1.0M | +50.1% |
| Financing Cash Flow | -$5.1M | -212.1% |
| Free Cash Flow | -$4.9M | +5.6% |